They do not affect cognitive function or motor skills in ways that create workplace safety concerns
doi.org/10.1111/jir.12283 Schoen SA, Lane SJ, Mailloux Z, May-Benson T, Parham LD, Smith Roley S, Schaaf RC
Recalls & Warnings May 01, 2024 FDA Warns Consumers Not to Use Ossos-Sans Supplement for Joints On April 17, 2024, the FDA warned consumers not to purchase or use Ossos-Sans, a supplement promoted to treat osteoarthritis, osteoporosis, and other conditions, because it contains undeclared drugs, including diclofenac and methocarbamol
This is harder to detect because it requires noticing the absence of expected effects rather than the presence of visible problems